Very Early Molecular Response at 1 Month Is a Predictor of the Outcome of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Won-Sik Lee; Hye-Young Song; Hyeoung‐Joon Kim; Jee Hyun Kong; Young Rok; Jae‐Yong Kwak; Sukjoong Oh; Sung‐Hyun Kim; Jeong‐A Kim; Dae Young Zang

doi:10.1182/blood.v130.suppl_1.1593.1593

Very Early Molecular Response at 1 Month Is a Predictor of the Outcome of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Identifier:nobleid.org/w1/20260515/337CD75F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/337CD75F.svg?ark=w1%2F20260515%2F337CD75F)](https://nobleid.org/work/w1/20260515/337CD75F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Very Early Molecular Response at 1 Month Is a Predictor of the Outcome of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Identifier:nobleid.org/w1/20260515/337CD75F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/337CD75F.svg?ark=w1%2F20260515%2F337CD75F)](https://nobleid.org/work/w1/20260515/337CD75F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work